Overview
8-Bromo-3-Methyl Xanthine is a high-purity active pharmaceutical ingredient (API) in the API Intermediate therapeutic category. 8-Bromo-3-methylxanthine is a key xanthine intermediate used in the manufacture of bronchodilator and DPP-4 inhibitor APIs.
Therapeutic Application
This compound serves as a critical synthetic building block in the multi-step manufacture of finished active pharmaceutical ingredients. It is supplied for industrial use only and is not intended for direct human or veterinary administration.
Specifications
- CAS Number: 93703-24-3
- Appearance: Clear liquid to crystalline solid depending on grade
- Typical Assay/Purity: ≥ 98.0%
- Common Pharmacopeial Grades: Technical / Synthesis Grade
- Storage: Store in a cool, dry place, away from light
- Shelf Life: Typically 24 months under recommended storage conditions
Regulatory & Compliance
Pharmint Exports adheres to WHO-GMP manufacturing practices, ensuring that 8-Bromo-3-Methyl Xanthine is produced in compliance with international quality standards. Availability of regulatory documents such as USDMF, CEP, and EU-GMP certificates, along with Certificates of Analysis (COA) and Certificates of Suitability (COS), is subject to inquiry.
Packaging & Shipping
8-Bromo-3-Methyl Xanthine is packaged in 25kg HDPE drums with double LDPE liners, palletized for secure transport. All necessary export documentation is provided, facilitating shipping to key markets including USA, EU, Canada, SE Asia, LatAm, Africa, Middle East.
Common Use Cases & Finished Dosage Forms
This API is typically incorporated into various dosage forms including:
- Not applicable – used as a synthesis intermediate
Ordering Information
The minimum order quantity (MOQ) for 8-Bromo-3-Methyl Xanthine is subject to inquiry. Interested parties are encouraged to request a Certificate of Analysis (COA) and a quote via this listing. For further inquiries, please contact Pharmint Exports directly.
Revisiones
There are no reviews yet.